Lenz Therapeutics, Inc. · NASDAQ:LENZ
FMR LLC reported a 15.00% stake in Lenz Therapeutics, Inc. (Schedule 13G)
Event Oct 31, 2025 · Filed Nov 7, 2025
FMR LLC reported a 15.00% stake in Lenz Therapeutics, Inc., 4,278,244 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G).
- Stake
- 15.00%
- Shares
- 4,278,244
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 15.00% | 4,278,244 |
| Abigail P. Johnson | 15.00% | 4,278,244 |
Source
Related
- Lenz Therapeutics, Inc.
- FMR LLC
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G/A · FMR LLC · Feb 5, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026